Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study

BACKGROUND/AIMS: Adalimumab has been shown to induce and maintain clinical remission in patients with moderate to severe ulcerative colitis (UC). However, no large-scale population-based studies have been performed in Japan. This study was conducted to evaluate the safety and effectiveness of adalim...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogata, Haruhiko, Hagiwara, Takashi, Kawaberi, Takeshi, Kobayashi, Mariko, Hibi, Toshifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566831/
https://www.ncbi.nlm.nih.gov/pubmed/33166442
http://dx.doi.org/10.5217/ir.2020.00033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566831/
https://www.ncbi.nlm.nih.gov/pubmed/33166442
http://dx.doi.org/10.5217/ir.2020.00033

Ejemplares similares